EUVIMEDEUVIMED entdecken
Crossref

ANTIFUNGAL RESISTANCE IN DERMATOMYCOSES: CURRENT TREATMENT CHALLENGES

М Maxmudjonov

CENTRAL ASIAN DERMOTOLOGY · 14.10.2026 · 17 (3) · 112

DOI: 10.67620/dermajournal.1730075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CENTRAL ASIAN DERMOTOLOGY, online erschienen am 14.10.2026. Verfasst von М Maxmudjonov.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dermatomycoses affect an estimated 20–25% of the global population. Over the past five years, this burden has been compounded by the rapid emergence of Trichophyton indotineae, a terbinafine-resistant dermatophyte first identified on the Indian subcontinent and now documented across more than 40 countries (da Silva et al., 2026). Reported resistance rates for this pathogen vary considerably across the literature, ranging from 5% to over 77%, a discrepancy risking misinterpretation as inconsistent evidence rather than a predictable consequence of study design.

Zitieren

APA

Maxmudjonov, М. (2026). ANTIFUNGAL RESISTANCE IN DERMATOMYCOSES: CURRENT TREATMENT CHALLENGES. CENTRAL ASIAN DERMOTOLOGY, 17(3), 112. https://doi.org/10.67620/dermajournal.1730075

Vancouver

Maxmudjonov М. ANTIFUNGAL RESISTANCE IN DERMATOMYCOSES: CURRENT TREATMENT CHALLENGES. CENTRAL ASIAN DERMOTOLOGY. 2026;17(3):112. doi:10.67620/dermajournal.1730075

BibTeX
@article{Maxmudjonov2026,
  author = {Maxmudjonov, М},
  title = {ANTIFUNGAL RESISTANCE IN DERMATOMYCOSES: CURRENT TREATMENT CHALLENGES},
  journal = {CENTRAL ASIAN DERMOTOLOGY},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {112},
  doi = {10.67620/dermajournal.1730075}
}
Kostenlos starten →